Skip to main content

Leo Luo, M.D.

  • Assistant Professor of Radiation Oncology

Leo Luo, M.D.

  • Assistant Professor of Radiation Oncology

leo.luo@vumc.org

Research Program

Research Description

Have any questions? Contact Us 1-877-936-8422 for more information

John Kuriyan, Ph.D.

  • Dean of the School of Medicine Basic Sciences
  • University Distinguished Professor of Biochemistry

John Kuriyan, Ph.D.

  • Dean of the School of Medicine Basic Sciences
  • University Distinguished Professor of Biochemistry

john.kuriyan@Vanderbilt.Edu

Research Program

Research Description

Have any questions? Contact Us 1-877-936-8422 for more information

Featured Speakers:

Mohammed AlQuraishi, PhD

(Columbia University)

is an Assistant Professor in the Department of Systems Biology and a member of Columbia’s Program for Mathematical Genomics, where he works at the intersection of machine learning, biophysics, and systems biology. Prior to starting his academic career, Dr. AlQuraishi spent three years founding two startups in the mobile computing space.

Avery Posey Jr., PhD

(University of Pennsylvania)

is an Assistant Professor in the Department of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania Perelman School of Medicine, a member researcher of the Parker Institute for Cancer Immunotherapy, and a Research Health Scientist at the Philadelphia Veterans Administration Medical Center. The Posey Laboratory generates novel CAR T cell therapies targeting tumor-associated glycosylation and investigates strategies to enhance CAR T cell persistence and overcome tumorinduced immunosuppression.

Sarah Teichmann, FMedSci FRS

(Wellcome Sanger Institute)

is a systems and genome biologist who heads the Cellular Genetics programme at the Wellcome Sanger Institute, Cambridge. Dr. Teichmann’s research group develops and applies cell atlasing technologies to map human tissue architecture in order to understand health and disease. In 2016, she co-founded the Human Cell Atlas (HCA) consortium, which she continues to co-lead. Dr. Teichmann is also the Director of Research at the Physics Department at the University of Cambridge.

Emerging Technologies in Cancer Research

Kevin Schey, Ph.D.

  • Professor of Biochemistry, Ophthalmology

Kevin Schey, Ph.D.

  • Professor of Biochemistry, Ophthalmology

k.schey@vanderbilt.edu

Research Program

Research Description

Have any questions? Contact Us 1-877-936-8422 for more information

Daniel Gochberg, Ph.D.

  • Professor of Radiology and Radiological Sciences and Physics and Astronomy

Daniel Gochberg, Ph.D.

  • Professor of Radiology and Radiological Sciences and Physics and Astronomy

daniel.gochberg@vumc.org

Research Program

Research Description

Have any questions? Contact Us 1-877-936-8422 for more information

Jessica Ancker, Ph.D., M.P.H.

  • Professor of Biomedical Informatics

Email

jessica.s.ancker@vumc.org
2525 West End Ave.

Jessica Ancker, Ph.D., M.P.H.

  • Professor of Biomedical Informatics

jessica.s.ancker@vumc.org

2525 West End Ave.

Research Program

Research Description

Have any questions? Contact Us 1-877-936-8422 for more information

‘Multi-omics’ reveals treatment option for breast cancer subtype

Submitted by vicc_migrate on
In a multidisciplinary collaboration, researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade immunotherapy.
Subscribe to